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Inherited diseases causedby geneticmutations can arise due to loss of protein function. Alternatively,mutated
proteins may mis-fold, impairing endoplasmic reticulum (ER) trafficking, causing ER stress and triggering the
unfolded protein response (UPR). The UPR attempts to restore proteostasis but if unsuccessful drives affected
cells towards apoptosis. Previously, we reported that inmice, the p.Tyr64Hismutation in the enamel extracellu-
lar matrix (EEM) protein amelogenin disrupts the secretory pathway in the enamel-forming ameloblasts, result-
ing in eruption of malformed tooth enamel that phenocopies human amelogenesis imperfecta (AI). Defective
amelogenin post-secretory self-assembly and processing within the developing EEM has been suggested to
underlie thepathogenesisofXchromosome-linkedAI.Here,wechallenge thisconceptbyshowingthatAIpatho-
genesis associated with the p.Tyr64His amelogenin mutation involves ameloblast apoptosis induced by ER
stress. Furthermore, we show that 4-phenylbutyrate can rescue the enamel phenotype in affected female mice
bypromotingcell survival over apoptosis such that theyareable tocomplete enamel formationdespite thepres-
enceof themutation, offeringapotential therapeutic option for patientswith this formofAI andemphasizing the
importance of ER stress in the pathogenesis of this inherited conformational disease.
INTRODUCTION
Membrane proteins and proteins destined for secretion are trans-
lated and simultaneously translocated into the rough endoplasmic
reticulum(ER)byER-boundribosomesfor traffickingto targetdes-
tinations. During translocation and subsequent trafficking, nascent
proteins begin to fold, attaining specific conformations that deter-
mineprotein functionality (1).Toaid this process,ER-resident cha-
perones bind client proteins and promote correct folding by
minimizing mis-folding and aggregation in a biologically relevant
timescale (2). However, physical or chemical stressors, genetic
mutations and advanced age are associated with an increased inci-
dence of protein mis-folding. Several major human diseases have
been attributed to protein mis-folding. These ‘conformational dis-
eases’, which include Alzheimer’s disease, Huntington’s disease,
Parkinson’s disease, atherosclerosis, cystic fibrosis and type 2
diabetes, arise when proteins fail to achieve their correct conform-
ation and aggregate in the ER due to exposure of hydrophobic
domains (3,4). Unfolded or mis-folded proteins are detected and
destroyed through ER-associated degradation (5) or autophagy
(6), and thus ER homeostasis is maintained. However, if the cap-
acity of the folding and degradation machinery is exceeded, mis-
folded proteins accumulate in the ER and cause ER stress (7).
Quality control systems in the ER centred on the transmembrane
receptors/transducers IRE1, PERK and ATF6, constantly monitor
the secretory cargo and on detection of an imbalance ofmis-folded
proteins trigger three intracellular pathways that together comprise
theunfoldedproteinresponse(UPR).TheUPRattempts toalleviate
ER stress by (i) decreasing protein synthesis, (ii) increasing the size
of the ER, (iii) increasing the synthesis of ER chaperones and (iv)
up-regulating components of the ER-associated degradation
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pathway. If homeostasis cannot be restored and ER stress is pro-
longed, the UPR can direct cells towards apoptosis (7,8).
Recently, we described a p.Tyr64His mutation in the develop-
ing enamel extracellular matrix (ECM) protein amelogenin in
mice that resulted in eruption of malformed tooth enamel that
exhibited severely compromised mechanical properties thereby
mirroring human amelogenesis imperfecta (AI) (9). AI is a
common genetic disorder with an incidence as high as 1 in 700
live births (10) which results in considerable morbidity, pain
and lowself-esteemdue topoor aesthetics (SupplementaryMater-
ial, Fig. S1) (11). Using this mouse model, we demonstrated that
the p.Tyr64His mutation apparently disrupts the secretory
pathway of the enamel-forming ameloblasts and speculated that
this phenomenon might lead to ER stress which has been shown
to be a factor in other inherited skeletal connective tissue diseases
involving mutations in secreted ECM proteins (12).
In the present study, we tested the hypothesis that the
p.Tyr64His amelogeninmutation results in an inherited conform-
ational disease thatmanifests as AI in thismousemodel. Our data
indicate that in the presence of themutation, amelogenin accumu-
lates intracellularly, inducing ER stress-related apoptosis in the
ameloblasts. As such, this is the first report classifying AI as a
conformational disease. Importantly, we also demonstrate that
4-phenylbutyrate dramatically rescues the phenotype in female
mice that are heterozygous for the mutation. Treatment options
for AI are limited and rely on costly and invasive restorative pro-
cedures. 4-Phenylbutyrate is already licensed for the treatment of
inborn errors of the urea cycle (unrelated to ER stress) where it
provides an alternative excretory route for the renal elimination
of amino acids (13).We suggest that 4-phenylbutyratemay be ef-
fective in the treatment of certain types of AI and other skeletal
connective tissue diseases related to ER stress associated with
the intracellular trafficking of mutated ECM proteins.
RESULTS
The ER secretory pathway is impaired in p.Tyr64His
amelogenin mutants
Histological analysis demonstrated that the cytoplasm in secre-
tory ameloblasts of affectedmicewas abnormally engorgedwith
multiple eosinophilic vesicles that were immuno-positive for
amelogenin and ameloblastin; the second most abundant
enamel ECM protein (Fig. 1A–I). Ultrastructural analysis sug-
gested that these vesicles formed within the ER and were asso-
ciated with a reduction in the volume of the Golgi apparatus
(Fig. 1J–L). Immunofluorescence analysis using antibodies to
ER resident proteins, proteins of the ER/Golgi intermediate
compartment/cis-Golgi and trans-Golgi showed that all but the
trans-Golgi proteins localized to the intracellular vesicles of
affected ameloblasts suggesting a collapse of the normal secre-
tory pathway (Fig. 2A–I; SupplementaryMaterial, Fig. S2A–I).
The p.Tyr64His amelogenin mutation induces an ER
stress response in ameloblasts
Todeterminewhether affected ameloblastswere under ER stress,
we performed in situ hybridization and quantitative RT–PCR to
investigate expression of ER stress genes. In situ hybridization
indicated increased Hspa5 expression, which encodes BiP, a
key component of the ER stress response (14) in secretory amelo-
blasts of affected mice compared with their wild-type littermates
(Fig. 3A and B). Similarly, quantitative RT–PCR analysis of
enamel organs containing secretory ameloblasts showed elevated
expression levels of ER stress genes Hspa5, Xbp1, Hspa90b1
(Grp94), Atf4 and Ddit3 (Chop) in affected mice compared with
their wild-type littermates (Fig. 3C).
4-Phenylbutyrate alleviates ER stress-induced apoptosis
in p.Tyr64His transfected COS-7 cells
To determine whether 4-phenylbutyrate was able to alleviate
the ER stress associated with the p.Tyr64His mutation, we
co-transfected COS-7 cells with p.Tyr64His amelogenin and
wild-type ameloblastin which resulted in a significant increase in
apoptosis (P, 0.0001) compared with controls transfected with
wild-type amelogenin or wild-type ameloblastin alone or in com-
bination.Crucially, apoptosiswasabrogatedbyadditionof0.5 mM
4-phenylbutyrate (SupplementaryMaterial, Fig. S3A). In parallel
experiments, the p.Pro70Thr amelogenin mutation which under-
lies AI in a human kindred (15), generated a similar increase in
apoptosis that was also abrogated by 4-phenylbutyrate (Supple-
mentary Material, Fig. S3B).
4-Phenylbutyrate improves the gross appearance of incisor
teeth in female mice carrying the p.Tyr64His amelogenin
mutation
In light of the in vitro transfection studies, we administered a diet
containing 7 g/kg sodium-4-phenylbutyrate to wild-type and
affected mice for 10 weeks while monitoring their continuously
erupting incisor teeth.Wild-type incisorswere smooth and opal-
escent throughout the experiment with no apparent differences
betweenmicemaintained on the control diet and those receiving
4-phenylbutyrate (Fig. 4A). At the outset of the experiment, the
incisor teeth of affected female mice were fractured/worn and
uneven, exhibiting a chalky-white appearance with roughened/
pitted surfaces phenocopying human AI (Fig. 4A). During the
course of the experiment, the incisors of both groups continued
to erupt. The majority of 4-phenylbutyrate-treated affected
female mice showed a marked improvement in the appearance
of their incisors over the course of the experiment with the poor-
quality enamel typically being replaced by translucent, shiny,
orange-coloured enamel characteristic of wild-type mice
(Fig. 4A and B). In contrast, the incisors of affected male mice
treated with 4-phenylbutyrate failed to show a similar improve-
ment presumably because they are hemizygous for amelogenin
and therefore produce exclusivelymutant protein. The defective
molar enamel in affected male and female mice was unaffected
by 4-phenylbutyrate treatment (Fig. 4A). This observation was
predicted since these teeth do not erupt continuously and
would have already completed their developmental program
prior to the mice receiving 4-phenylbutyrate.
4-Phenylbutyrate improves the p.Tyr64His phenotype
at the histological level
Histologically, wild-type mouse incisors showed typically tall
secretory-stage ameloblasts associated with an eosinophilic
enamel ECM (Fig. 4C). As the ameloblasts entered the
2 Human Molecular Genetics, 2014
 at U
niversity of Leeds on January 10, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
Figure 1.Secretory stage ameloblasts of affectedmalemicemanifest a defect in the amelogenin secretorypathway. (A)Wild-type secretory stage ameloblasts (n ¼ 3)
are organized as a tall columnar epitheliumwith secretoryTomes’ processes that inter-digitatewith the enamelECM(arrows). (B) In contrast, affectedmale secretory
ameloblasts (n ¼ 3) are shorter, lose their Tomes’ processes (blue arrows), exhibit highly eosinophilic cytoplasm (black arrows) and secrete less enamel ECM. The
secreted ECM shows a biphasic eosin staining patternwith the secretedmatrix (M′) deposited later in the secretory stage being less eosinophilic than that produced at
the earliest stages of amelogenesis (M). (C) The cytoplasmic vesicles observed in the secretory ameloblasts of affected male mice (n ¼ 3) are strongly
immuno-reactive for amelogenin (arrows) as is the secreted enamel ECM (asterisk). Scale bars: (A) and (B) 20 mm; (C) 10 mm. (D–F) Dual immunofluorescence
for amelogenin and ameloblastin demonstrates that both proteins co-localize in the cytoplasm (arrows) of wild-type mice (n ¼ 3). Nuclei are stained with DAPI
(blue). A, ameloblasts; M,matrix. Scale bars: 10 mm. (G–I) Dual immunofluorescence for amelogenin and ameloblastin demonstrates that both proteins co-localize
in the large cytoplasmic vesicles (arrows) (n ¼ 3). Nuclei are stainedwithDAPI (blue). A, ameloblasts. Scale bars: 10 mm. (J–L) Transmission electronmicroscopy
of secretory stage ameloblasts. (J) In wild-type mice (n ¼ 3), the ER is organized longitudinally and arranged peripherally close to the plasma membrane (white
arrows), while the Golgi apparatus and secretory granules are located towards the centre of the cell (red arrows). (K) In early secretory ameloblasts of affected
male mice (n ¼ 3), protein-containing inclusions form towards the periphery of the cell in the same region as the ER (white arrows) while the central area of the
cell lacks a recognizable Golgi apparatus but contains dilated cisternae (asterisk). (L) The membrane-bound inclusions in affected male mouse ameloblasts
enlarge progressively until they occupy the majority of the cellular volume (arrows). Scale bars: (D) and (E) 1 mm; (F) 500 nm.
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maturation stage, during which rapid crystal growth appears and
mineral contentdramatically increases, theyshortenedand thepro-
teinswere removed from the enamelECMasevidencedby the loss
of staining (Fig. 4C). In contrast, secretory ameloblasts in affected
female mice exhibited intracellular eosinophilic staining, indicat-
ing retainedmatrixprotein, and the lengthof the secretoryzoneand
thickness of the associated enamel ECM were reduced compared
withwild-typemice (Fig. 4CandD).Maturation stage ameloblasts
in affected female mice were highly disorganized with substantial
ECMretained in theunderlyingenamel (Fig. 4C).Similar analyses
of affected female mice that received 4-phenylbutyrate indicated
that these abnormalities were abolished, with the ameloblasts
and ECM being histologically indistinguishable from wild-type
mice (Fig. 4C and D). Image analysis indicated that the size of
thecytoplasmicvesiclesofaffectedmicewas reducedsignificantly
by 4-phenylbutyrate treatment (Fig. 5A).
Figure 2. Characterization of the cytoplasmic vesicles observed in affected male mice. (A–F) Dual immuno-staining for amelogenin (red fluorescence) or (G–I)
ameloblastin (red fluorescence) and components of the secretory pathway (green fluorescence) in affected male mice (n ¼ 4) secretory ameloblasts indicate arrest
of amelogenin trafficking at a stage prior to the trans-Golgi. (A) The ER membrane protein calnexin circumscribes the amelogenin-containing vesicles (arrows),
while the ER luminal molecule protein disulphide isomerase (B) co-localizes with amelogenin within the vesicles (arrows). (C) Immuno-reactivity for the ER/
Golgi intermediate compartment molecule Ergic 53 also co-localizes with amelogenin in the vesicles (arrows), whereas (D) b-COP, a component of COP1 vesicles
found at the cis-Golgi and ER/Golgi intermediate compartment, co-localizes with amelogenin at the periphery of the vesicles (arrows). (E) The cis-Golgi protein
GM130 co-localizes with amelogenin within the vesicles (arrows). (F) Golgin 245, a trans-Golgi protein, showed a variable pattern of immuno-reactivity; in most
instances, little amelogenin co-localization was observed in the vesicles (white arrows), although, less typically, partial or complete co-localization was seen
(green arrows). (G) Dual immunofluorescence for ameloblastin and the ER membrane protein calnexin indicates that calnexin circumscribes the inclusions
(arrows). (H)Similar analysesusingantibodiesdirectedagainst ameloblastin and theER luminalmoleculeproteindisulphide isomerase (PDI) indicate co-localization
within the vesicles (arrows). (I) In contrast, dual immunofluorescence with ameloblastin and Ergic 53, a protein found in the ER/Golgi intermediate compartment,
demonstrates distinct localization within the ameloblasts (arrows). Nuclei are stained with DAPI (blue). Scale bars: 5 mm.
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4-Phenylbutyrate appears to rescue the p.Tyr64His
phenotype by inhibiting apoptosis
Westernanalysis of secretory stageECMfromaffectedmalemice
revealed that amelogenin secretion was still impaired despite
4-phenylbutyrate treatment, suggesting that the therapeutic
value of 4-phenylbutyrate was not linked to a restoration of the
normal secretory pathway in affected ameloblasts (Fig. 5B). We
could not, however, analyse affected female mice in this way; in
these mice, 50% of the ameloblasts are expressing wild-type
amelogenin, and the enamelmatrix is rich in normal amelogenins.
Against this amelogenin-rich background, it is impossible tovisu-
alize anyeffect of4-phenylbutyrateon the secretoryactivityof the
remaining 50% of ameloblasts expressing mutant amelogenin.
To determine whether the observed therapeutic value of
4-phenylbutyrate was linked to modulation of the UPR such that
ameloblast survival was promoted over apoptosis, we compared
levels of activated caspase 3 in ameloblasts of affected mice
with or without 4-phenylbutyrate treatment. In the absence of
4-phenylbutyrate, large numbers of ameloblasts were immuno-
positive for activated caspase 3 whereas treatment with
4-phenylbutyrate reduced activated caspase 3 levels to those
seen in wild-type mice, indicating that 4-phenylbutyrate was
indeed inhibiting ameloblast apoptosis in affected animals
(Fig. 5C and D and Supplementary Material, Fig. S4).
4-Phenylbutyrate treatment restores enamel
micro-architecture and mineral density in affected
female mice
To assess the effect of 4-phenylbutyrate treatment on the enamel
mineral phase in affected animals, we employed high-resolution
X-ray computed tomography (CT) and scanning electronmicros-
copy (SEM). CT demonstrated that the incisor enamel of affected
female mice was hypomineralized, with the mature enamel
exhibiting a roughened, hypoplastic appearance (Fig. 6A and B,
and Supplementary Material, Video S1). Treatment with
4-phenylbutyrate dramatically improved both the quantity and
quality of enamel in affected female mice, restoring mineral
density to that observed in wild-type mice in the majority of
caseswith no remaining evidence of hypoplasia (Fig. 6C andSup-
plementaryMaterial, Video S1). SEM showed that the enamel of
affected female mice was biphasic with a layer of inner enamel
that appeared normal exhibiting the distinctive decussating ar-
rangement of enamel rods characteristic of rodent incisor
enamel micro-architecture. In contrast, the outer enamel layer
was structurally abnormal with a loss of decussation and a reduc-
tion in the number of enamel rods present (Fig. 6A and B).When
affected female mice were treated with 4-phenylbutyrate, the
whole enamel architecture was dramatically restored to that
observed inwild-typemicewith decussating enamel rods travers-
ing the full thickness of the enamel without interruption (Fig. 6A
and C).
The effect of 4-phenylbutyrate treatment on affected
male mice is limited
In contrast to affected female mice, there was no similar im-
provement in the gross appearance of incisor enamel in affected
male mice following 4-phenylbutyrate treatment. However,
4-phenylbutyrate treatment resulted in a significant increase in
the length of the organized secretory zone and matrix thickness
in affected males (Supplementary Material, Fig. S5A) and the
number of apoptotic cells was reduced (Supplementary Mater-
ial, Fig. S5B and C). CT and SEM indicated that affected male
incisor enamel remained severely hypoplastic with only a super-
ficial layer of rod-free enamel present on the tooth surfaces. In
contrast to affected female mice, 4-phenylbutyrate treatment
Figure 3. The p.Tyr64His mutation in amelogenin results in ER stress increased intermolecular interactions of mutant amelogenins. (A and B) In situ hybridization
indicates that the secretory stage ameloblasts of affected femalemice (n ¼ 3) (B) expressHspa5 (BiP)more strongly thanwild-type littermates (n ¼ 3) (A). Scale bar:
10 mm. (C)Real-timePCRanalysis ofmicro-dissected secretory enamel organs indicates that the levels ofER stress responsegenes are elevated in affectedmice (n ¼
4) compared with wild-type (n ¼ 4) littermates. P ¼ 0.014, Hspa5, Hspa90b1, Atf4 and Ddit3; P ¼ 0.043 Xbp1.
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Figure 4. Phenotypic rescue using 4-phenylbutyrate in vivo. (A) The incisor teeth of wild-type mice are smooth and opalescent while those of affected female mice
exhibit a chalky-white, opaque appearance with roughened/pitted surfaces. 4-Phenylbutyrate treatment restores the appearance of affected female mice incisors to
wild type. In contrast, phenotypic rescue of the molar teeth, which do not erupt continuously, is not observed. (B) Qualitative assessment of the enamel appearance
by independent researchers. This difference is statistically significant (Fisher’s exact test; P ¼ 0.019). (C) Histological analysis indicates that the tall columnar se-
cretory stage ameloblasts of wild-type mice secrete a thick, eosinophilic, enamel ECMwhile the maturation stage ameloblasts are shorter and the enamel ECM has
been digested (asterisk). The secretory ameloblasts of untreated affected femalemice are disorganizedwith intensely eosinophilic cytoplasmand numerous apoptotic
cells (arrows). A thinner enamel matrix has been secreted. At the maturation stage, multicellular masses of ameloblasts have formed around retained enamel ECM.
Manyof the ameloblasts are apoptotic (arrows).By contrast, the histological appearanceof the enamel organof 4-phenylbutyrate-treated affected femalemice closely
resembles that ofwild-typemicewith onlyoccasional secretoryameloblasts displayinga strongly eosinophilic cytoplasm(arrows).A, ameloblasts;M, enamelmatrix.
Scale bars: 50 mm. (D)Morphometric analysis of the enamel organ indicates that the length of the ameloblast secretory zone (P ¼ 0.0031) and themaximumthickness
of the enamel ECM (P ¼ 0.0064) deposited is increased in affected female mice treated with 4-phenylbutyrate. PB-treated mice, n ¼ 15; control mice, n ¼ 12.
PB, 4-phenylbutyrate. Error bars represent the standard deviation of the mean for all datasets.
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Figure 5.Effect of PB treatment on the secretory stage enamel organ. (A)Effect of 4-phenylbutyrate (PB) treatment on the size of cytoplasmicvesicles inmutantmice.
Ameloblastin immuno-staining was used to delineate the cytoplasmic vesicles in the secretory stage ameloblasts of untreated and PB-treated affected female and
affected male mice with image analysis being used to determine their area. As indicated in the scattergram, the distribution of vesicle area shifted to lower values
in PB-treated affected female and affected male mice compared with their untreated littermates. Four mice were examined, and three images analysed in each
group. Comparison of the median values using Kruskal–Wallis analysis followed by a Dunn’s multiple comparison test showed highly significant differences in
vesicle size between untreated and PB-treated mice of both genotypes (P , 0.0001). In contrast, there was no statistically significant differences in median
vesicle size between PB-treatedmale and PB-treated femalemice (P ¼ 0.064). (B)Western blotting of secretedmatrix proteins suggests that PB does not completely
relieve secretory impairment. Two wild-type, four PB-treated affected male and two untreated affected male mice were analysed. (C and D) Activated caspase 3
immuno-staining was used to identify secretory stage ameloblasts undergoing apoptosis in untreated and PB-treated affected female mice. In untreated mice (C),
numerous apoptotic cells were observed (arrows) while in the PB-treated affected female mice (D), fewer apoptotic cells were detected (arrows). Three mice
were examined in each group. Scale bars: 100 mm.
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failed to rescue this situation (Supplementary Material,
Fig. S5D–F).
DISCUSSION
Anumber of serious humandiseases are associatedwithERstress
induced by the mis-folding of newly synthesized proteins as they
are trafficked through the ER (4,5,12,17,18). Even under normal
circumstances, up to 30% of proteins fail to fold correctly (19).
The UPR, acting as a cellular quality control system, protects
cells from the cytotoxic effects ofmis-folded proteins by increas-
ing the availability of chaperones and/or directingmis-folded pro-
teins to the ER-associated degradation pathway for destruction to
restorehomeostasis.However, if theamountofmis-foldedprotein
exceeds thecapacityof theUPRtomaintainhomeostasis, theUPR
commits the cell to apoptosis (20).The threeERstress transducers
IRE1, ATF6 and PERK are activated by rising levels of mis-
folded proteins in the ER triggering the UPR. Although not
fully understood, integration of the myriad signals cascading
from activation of IRE1, ATF6 and PERK dictates whether cell
survival or apoptosis is favoured (21).
Previously, we have demonstrated that the p.Tyr64His muta-
tion inmurine amelogenin results in dental anomalies that pheno-
copyX-linkedAIobserved in humans (9).Here,we show that this
phenotype arises due to impairment of the normal ameloblast se-
cretory pathway leading to ER stress and large-scale ameloblast
apoptosis rather than as a result of post-secretory amelogenin dys-
function in the developing enamel ECM. Wild-type secretory
ameloblasts constitutively utilize the UPR as they exhibit
increased levels of activated IRE1 and its downstream target
XBP-1 (16), a transcription factor targetingmultiple downstream
target genes the majority of which are involved in increasing the
folding capacity of the ER or with the degradation of proteins ac-
cumulating in the ER (22,23). This process is typical of cells with
high secretory activity and a large flux of proteins passing through
the ER such as ameloblasts, pancreatic b-cells and plasma cells,
as it aids physiological adaptation to the large secretory load
(14,24).However, thepresenceof p.Tyr64Hismutant amelogenin
in the ameloblast secretory cargo clearly exceeds the capacity of
the UPR to maintain ameloblast homeostasis as evidenced by
the breakdown of the normal secretory machinery and intracellu-
lar accumulation of amelogenin in vesicles apparently composed
of the disorganized remnants of the ER-Golgi secretory pathway
(Figs 1 and 2 and Supplementary Material, Fig. S2).
Our data show that the p.Tyr64His amelogenin mutation is
associated with an up-regulation of several UPR-associated
genes including Hspa5, Xbp1, Hspa90b1, Atf4 and Ddit3
(Fig. 3) presumably induced by the observed ER stress and
Figure 6. Characterization of phenotypic rescue achieved with 4-phenylbutyrate. (A) SEM of wild-type incisors showing ordered decussating enamel rod structure
(E) and transverse and longitudinal CT scans (calibrated formineral density) showing the dense enamel layer overlying dentine (D). The cartoon shows enamel being
deposited by ameloblasts during the secretory stage as the tooth erupts left to right.Maturation stage ameloblasts shorten as the enamel attains its finalmineral density.
To accommodate the large secretory cargo transiting the ER and spontaneously mis-folded/aggregated wild-type amelogenin (depicted in red), the UPR is activated,
IRE1 is activated in secretory ameloblasts (16) and cell survival is promoted. (B) The enamel of affected female mouse incisors is biphasic with an inner layer of
apparently normal decussating enamel (35 mmthick) and an outer layer containing fewer, disorganizedprisms.Outer enamel is frequentlymissinghaving fractured
along the inner–outer enamel boundary (dashed line). The increase in mis-folded/aggregated mutated amelogenin accumulating in the ER is tolerated initially and
enamel secretion is unaffected. However, after 35 mm of enamel is deposited, the increasing burden of ER stress drives the UPR towards an apoptotic endpoint.
Those ameloblasts expressing p.Tyr64His amelogenin die, resulting in disruption of the ameloblast layer which compromises subsequent enamel deposition.
(C) 4-Phenylbutyrate restores the decussating prism structure and appearance of the enamel layer to wild type. Western blotting (Fig. 5B) and cellular retention of
eosinophilic vesicles (Fig. 4C) indicate that 4-phenylbutyrate does not greatly improve amelogenin secretion.We therefore suggest that 4-phenylbutyrate modulates
theUPR response in favour of survivalmeaning that a functional ameloblast layer ismaintained and enamel deposition proceeds undisturbed even though amelogenin
secretion is presumably reduced owing to cellular retention of mutated protein. Three mice were examined in each group. PB, 4-phenylbutyrate.
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indicating that the UPR has been further activated to levels over
and above that deployed for cell homeostasis in wild-type ame-
loblasts. Ddit3 encodes the transcription factor Chop which is
induced by activation of IRE1, PERK and ATF6 that then acti-
vates downstream apoptosis pathways (25). Together with the
presence of an activated caspase cascade (Fig. 5C and Supple-
mentary Material, Fig. S5C), the data indicate that p.Tyr64His
amelogenin aggregates, stalled in the secretory pathway, over-
whelm the ability of the UPR to restore homeostasis and
instead the UPR drives the ameloblasts towards apoptosis.
Amelogenesis involves the incremental secretion of a protein-
rich ECM onto the pre-formed underlying dentine by the amelo-
blastmonolayer (26). The partiallymineralized ECM is primarily
composed of amelogenin and its extracellularly derived process-
ing products. Once the full thickness of the enamel layer is
secreted, delineating final enamel thickness, the ECM proteins
are degraded. The enamel then enters a maturation stage as the
ameloblasts pump mineral ions into the ECM permitting the
thin, pre-existing crystals to grow in width and thickness so that
the tissue is eventually 90%mineral by volume thus becoming
the most highly mineralized and hardest skeletal connective
tissue. Rodent incisors erupt continuously to compensate for
tooth wear caused by gnawing with newly differentiated amelo-
blasts appearingat the root apex tobegin the incremental secretion
of the enamel ECM as the tooth erupts. The complete process of
enamel formation from initial matrix secretion to the eruption of
mature enamel is therefore spatially laid out in a predictable se-
quence along the incisor, which makes the rodent incisor the
ideal model to study all aspects of amelogenesis in a single
tooth (27). The histological, SEM and CT data (Figs 4C, D and
6) indicate that femalemiceheterozygous for thep.Tyr64Hisame-
logenin mutation secrete a biphasic enamel comprising an initial
enamel layer 35 mm in thickness that is apparently normal.
After this initial enamel layer is laid down, the ameloblasts
become disorganized and any enamel elaborated after this point
is abnormal, with reduced rod density, or is absent altogether. As-
suming an enamel apposition rate of 6 mm per day (28) it can be
estimated that the ameloblasts take6 days to deposit the appar-
ently normal initial 35 mm of enamel. During this time, the ame-
loblast monolayer remains intact and the enamel produced
appears structurally normal. Presumably, during this period, the
UPR is permissive for affected ameloblast survival and the integ-
rity of the ameloblast monolayer is maintained. However, after
this time, increasing pro-apoptotic signals in affected ameloblasts
appear to tip thebalance in favourof apoptosis resulting ina lossof
those ameloblasts carrying the amelogenin mutation (50% of
the ameloblasts are lost assuming randomX-chromosome inacti-
vation) and subsequent disruption of the ameloblast monolayer.
This explains the apparent reduction in rod density in the
enamel laid down on top of the initially secreted 35 mm layer
(Fig. 6B) in affected animals since each rod is thought to be the
product of a single ameloblast (26).
Having concluded that the p.Tyr64His phenotypewas a result
of induced ER stress and subsequent UPR-mediated ameloblast
apoptosis, we hypothesized that 4-phenylbutyrate,which can act
to relieve conformational disease pathology, would rescue the
phenotype. 4-Phenylbutyrate has been investigated in clinical
trials and in vivo and in vitro experimental studies as a potential
therapeutic agent for the treatment of several diseases including
cancer, spinal muscular atrophy, ischaemia, cystic fibrosis and
Huntington’s disease (13).
We found thatCOS-7 cells co-transfectedwith both p.Tyr64His
amelogenin and ameloblastin underwent apoptosis but apoptosis
was abolished with 4-phenylbutyrate treatment. Moreover, the
known human amelogeninmutation Pro70Thr (15) also promoted
apoptosis in COS-7 cells when co-expressed with ameloblastin. It
has previously been suggested that human Pro70Thr amelogenin-
linkedAI is due to themutation inhibiting enamel crystal growth in
the enamel ECM based on in vitro data (29). Our COS-7 data
suggest that ameloblast ER stress may also play a role in this spe-
cific example of human AI. The significance of the fact that
mutated amelogenin is only apoptotic when co-expressed with
ameloblastin is unclear.
Building on these cell transfection studies, we tested the effi-
cacy of 4-phenylbutyrate in rescuing the p.Tyr64His phenotype
in vivo. Following dietary administration of 4-phenylbutyrate,
we observed a remarkable improvement in the phenotype of
p.Tyr64His female mice, macroscopically, histologically and
ultrastructurally. Importantly, the numbers of apoptotic cells
were reduced to the level seen in wild-type mice. Restoration
of the normal enamel architecture by 4-phenylbutyrate explains
the observed improvement in enamel strength and the uniform
undamaged appearance of the biting edge as the characteristic
decussating structure dictates the physical properties of the
tissue.
Previous reports indicate that 4-phenylbutyrate acts as a syn-
thetic chaperone that directly interacts with the ER’s secretory
load to restore normal secretory function and a return to health
(30,31).However,western blotting showed that 4-phenylbutyrate
did not obviously improve the secretion of p.Tyr64His amelo-
genin into theECMand theECMremaineddeficient in full-length
amelogenin compared with wild-type littermates. The results
therefore suggest that 4-phenylbutyrate does not act as a chaper-
one in this mouse model of AI. Instead, 4-phenylbutyrate
appears to inhibit ameloblast apoptosis, as indicated by its
ability to return levels of affected ameloblasts immuno-positive
for activated caspase 3 to wild-type levels.
In female heterozygous p.Tyr64Hismice, 4-phenylbutyrate dra-
matically rescued the enamel phenotype even though only 50%
of the ameloblasts would be expressing wild-type amelogenin
and contributing to matrix deposition as the affected ameloblasts
are still compromised in terms of amelogenin secretion.
However, the inhibition of apoptosis in the affected ameloblasts
by 4-phenylbutyrate preserves the structural integrity of the amelo-
blast monolayer allowing the cohort of wild-type ameloblasts to
depositacomplete, structurallynormalenamel layer in thepresence
of affected ameloblasts. In contrast, although 4-phenylbutyrate
improved the ameloblast histology in male mice (hemizygous for
p.Tyr64His amelogenin), the phenotype was not rescued presum-
ablybecauseallof theameloblastsareaffectedandexhibit impaired
amelogenin secretion.
How 4-phenylbutyrate promotes ameloblast survival over
apoptosis in the presence of the mutation is unclear but
4-phenylbutyrate is a known histone deacetylase inhibitor (32)
and can exert an impact on the transcription of multiple genes
regulating apoptosis and also promote survival over apoptosis
within certain cellular contexts (33–35). A scheme outlining
the possible interactions of 4-phenylbutyrate with components
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of theUPR-induced apoptotic signalling pathway is presented in
Supplementary Material, Figure S6.
In summary, our findings position this particular case of AI
amongst the conformational diseases. As such, we present a
new concept to explain the molecular pathogenesis of an inher-
ited disease in a mouse model with direct relevance to the same
condition in humans.We show that 4-phenylbutyrate can rescue
the disease phenotype by inhibiting apoptosis in affected cells.
Sodium-4-phenylbutyrate isFDA-approvedand iswell tolerated
when administered at high doses as an ammonium scavenger in
the treatment of human urea cycle disorders (13). Our observa-
tions therefore raise the possibility of treating at least a subset
of human AI cases by administering sodium-4-phenylbutyrate
from birth while the permanent dentition is developing. The
murine AI model described here may also provide a useful tool
to aid in our further understanding of ER stress in the future.
MATERIALS AND METHODS
Mice
Themutantmouse lineM100888was obtained fromRIKENGSC
(http://www.gsc.riken.jp/Mouse/) and maintained on a DBA/2J
genetic background. Control mice (n¼ 19) were fed a standard
proprietary rodent diet (Special Diet Services, UK) while drug-
treated mice (n¼ 22) were fed the same diet containing 7 g/kg
sodium-4-phenybutyrate over a 10-week period.Mice were geno-
typed by PCR amplification of the genomic region containing
Amelx exon 5 (forward primer sequence: 5′-ATGATAAGGCAG
CCGGTATA-3′; reverse primer sequence: 5′-GTGATGAGG
CTGAAGGGTGT-3′) followed by sequencing of the PCR
product using dye primer chemistry (primer sequence:
5′-CACCTTCAAACACTAATGGG-3′). All experiments were
performed in accordancewith theAnimals (Scientific Procedures)
Act, UK, 1986. Unless otherwise stated, all experiments were per-
formed using affected heterozygous female or affected hemizy-
gous male Amelxmutant mice and their wild-type littermates.
High-resolution immunofluorescence analysis
Following cervical dislocation, hemi-mandibles dissected from
wild-type (n ¼ 3) and affected male mice (n ¼ 3) were fixed in
4% paraformaldehyde in 0.1 M cacodylate buffer (pH 7.4) over-
night at 48C, rinsed in phosphate-buffered saline (PBS) and
demineralized for 3weeks in0.5 MEDTA,pH7.0. Followingde-
mineralization, samples were re-fixed with 4% paraformalde-
hyde in 0.1 M cacodylate buffer (pH 7.4) overnight. Next
morning, samples were dehydrated through a graded ethanol
series and embedded as transverse segments, corresponding to
the secretory and maturation regions of the tooth, in acrylic
resin (LR White) and polymerized at 408C for 24 h. Semi-thin
sections were prepared using a glass knife and mounted on
Superfrost Plus glass slides (Thermo Shandon).
Dual immunofluorescence was performed for amelogenin
(FL191, Santa Cruz Biotechnology) and ameloblastin (C17,
Santa Cruz Biotechnology). Primary antibodies were detected
using Alexa Fluor 488 (amelogenin) and Alexa Fluor 555 (amelo-
blastin)conjugatedsecondaryantibodies (Invitrogen)andmounted
inMowiol 4–88mountingmedium containing 2.5%DABCO and
0.1% DAPI. Immunolabelled sections were examined on a Delta
Vision RT (Applied Precision) restoration microscope. Images
were collected using a Coolsnap HQ (Photometrics) camera with
aZoptical spacing of 0.2 mm.Raw imageswere then deconvolved
using Softworx software and displayed asmaximum intensity pro-
jections.
Transmission electron microscopy
Two-month-oldmousemandibles (fourwild-typemale and four
affected male mice) were dissected following cervical disloca-
tion and fixed in 2% paraformaldehyde/2% glutaraldehyde pre-
pared in 0.1 M cacodylate buffer containing 0.15 M sucrose and
2 mM calcium chloride (pH 7.3) at 48C overnight. Hemi-
mandibles were demineralized as above and dissected axially
into posterior, medial and anterior portions. Following dissec-
tion, the sampleswerewashedwith cacodylate buffer, post-fixed
in 1% osmium tetroxide, dehydrated through a graded ethanol
series, cleared in propylene oxide and embedded in Epoxy
resin (100 resin, Agar Scientific Ltd.). Ultrathin sections were
contrasted with uranyl acetate and lead citrate, and examined
on a Philips model 400 transmission electron microscope.
Immunofluorescence analysis of the enamel organ
Mandibles from 3-month-old affected male mice and wild-type
mice (n ¼ 4 in each category) were dissected following cervical
dislocation and fixed in 4% paraformaldehyde dissolved in PBS
(pH 7.4) for 24 h. Following fixation, the mandibles were demi-
neralized as above, dehydrated through a graded ethanol series,
cleared in chloroform, embedded as hemi-mandibles in paraffin
wax and sectioned onto Superfrost Plus glass slides (Thermo
Shandon). Immunofluorescence was performed using primary
antibodies to amelogenin (FL191; Santa Cruz Biotechnology),
calnexin (C4731; Sigma-Aldrich), protein disulphide isomerase
(P7496; Sigma-Aldrich), ER-Golgi intermediate compartment
protein 53 kDa (ERGIC 53, sc-66880; Santa Cruz Biotechnol-
ogy), cis-Golgi matrix protein 130 kDa (GM 130, sc-55590;
Santa Cruz Biotechnology), Golgin 245 (sc-102565; Santa
Cruz Biotechnology) and activated caspase 3 (AF835; R & D
Systems). The rabbit anti-b-COP antibody, EAGE, was raised
in the laboratory of Professor Thomas Kreis (deceased) and pro-
vided byMartinLowe (University ofManchester). Primary anti-
bodies were detected using Alexa Fluor 488- or Alexa Fluor
555-conjugated secondary antibodies (Invitrogen) and
mounted in Mowiol 4–88 mounting medium containing 2.5%
DABCOand 0.1%DAPI. Imageswere collected using deconvo-
lution microscopy as described above.
In situ hybridization and quantitative PCR analysis of ER
stress markers
A 350 bp fragment of BiP cDNA (IMAGE clone ID6334883)
was cloned into pBluescript SK (Stratagene) and the resulting
construct used to synthesize digoxygenin-labelled sense and
antisense riboprobes using digoxygenin-conjugated dUTP
(Roche) andT7 andT3RNApolymerase (Promega), respective-
ly. In situ hybridization was performed as described previously
(36,37); however, riboprobebindingwasdetected immunohisto-
chemically using an alkaline phosphatase-conjugated, anti-
digoxygenin antibody (Roche) followed by histochemical
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demonstration of alkaline phosphatase activity using BMpurple
(Roche) as the chromogenic substrate. Endogenous alkaline
phosphatase activity was inhibited using levamisole. Paraffin
wax-processed sections (6 mm) of three hemi-mandibles from
affected female, affected male and wild-type mice were
examined.
For quantitative PCR analysis total RNA was extracted using
the RNeasy kit (Qiagen, Crawley, UK) from micro-dissected
secretory-stage enamel organs (4 wild-type, 4 homozygous
femalemice), quantified using aNanoDrop 2000 spectrophotom-
eter (ThermoShandon),andreverse transcribed tocomplementary
DNA. Quantitative reverse transcriptase–PCR was performed
according to the manufacturer’s instructions on a StepOne Plus
machine using SYBR Green master mix (Life Technologies,
Paisley, UK) and analysed using the DD-Ct method, normalized
to b-actin. Results were analysed using a one-tailed Mann–
WhitneyU-test. The followingprimer pairswereused for the ana-
lysis: hspa5 5′-ATCTTTGGTTGCTTGTCGCT-3′, 5′-ATGA
AGGAGACTGCTGAGGC-3′; Xbp1 5′-CCGTGAGTTTT
CTCCCGTAA-3′, 5′-AGAAAGAAAGCCCGGATGAG-3′;
Hsp90b1 5′-TTGTGTCCAATTCAAGGTAATCA-3′, 5′-TTGC
TGACCCAAGAGGAAAC-3′; Atf4 5′-TTGTCCGTTACAGC
AACACTG-3′, 5′-GCAGCAGCACCAGGCTCT-3′;Ddit35′-GA
CCAGGTTCTGCTTTCAGG-3′, 5′-CAGCGACAGAGCCAGA
ATAA-3′.
Western blotting
Following cervical dislocation,mandibular incisor teethweredis-
sected free of the mandibular bone and the enamel organ gently
wiped off the enamel surface with a moist paper tissue. Enamel
corresponding to the secretorystagewasdissected fromtheunder-
lying dentine and immediately frozen in liquid nitrogen prior to
storage at 2808C. Enamel samples were extracted directly into
25 ml of SDS–PAGE sample loading buffer (38) containing a
cocktail of enzyme inhibitors (Roche). Samples were heated at
908C for 2 min and loaded onto 12% SDS–PAGE gels
(Bio-Radmini protean III) and electrophoresed at 200 V. Follow-
ing SDS–PAGE gels were electro-blotted onto nitrocellulose at
80 V for 1 h. Blots were blocked by overnight incubation at 48C
in 5%milk powder in TBS. After blocking, blots were incubated
with primary antibody raised in rabbit against full-length human
recombinant amelogenin (Santa Cruz SC-32892) diluted 1:1000
in TBS + 0.05% Tween 20 (TBST) for 1 h at room temperature.
Excess antibody was removed by washing with TBST (3×
5 min). The blot was incubated with anti-rabbit IgG peroxidase
conjugate (SigmaA0545) diluted 1:2000 for 1 h at room tempera-
ture. Excess antibody was removed by washing with TBST (5×
5 min) and immuno-reactivity revealed by staining with
metal-enhanced DAB (Sigma D0426) used in accordance with
the manufacturer’s instructions.
High-resolution X-ray CT
Following dissection of secretory stage enamel, incisor teeth
were glued to glass microscope slides and mounted in polypro-
pylene tubes for CT scanning. Scans were obtained using a
high- resolution X-ray CT system (Phoenix Nanotom 160 NF
GE, Germany) operated at a tube voltage of 80 kV, current
100 mA and irradiation time of 1000 ms. Images were recorded
as the sample was rotated through 3608 in incremental steps of
0.258 generating a total of 1440 images. Resolution was 7 mm
per voxel. A transverse section through a mature incisor from a
wild-type mouse was used as an internal calibration standard.
The mineral density of the standard had been previously deter-
mined by transverse microradiography.
Resulting scans were analysed and processed using ImageJ
software.
Scanning electron microscopy
Incisors previously subjected toX-rayCT scanningwere ground
with fine carborundum paper to obtain transverse sections
through the incisor 2 mm from the incisal tip. Any smear
layer was removed by etching the ground surface in 30% phos-
phoric acid for 20 s followed by thorough rinsing in excess dis-
tilled water. Teeth were dried overnight under vacuum and
sputter coated with gold. Specimens were observed using a
Hitachi S-3400N scanning electron microscope operated at an
accelerating voltage of 20 kV and an emission current of 82 mA.
Transfection experiments
COS-7 cells were cultured on coverslips in DMEM containing
10% fetal bovine serum at 378C and 5% CO2. Once cells had
reached80%confluence, single transfectionsandco-transfections
were established using the wild-type amelogenin, p.Tyr64His
mutant amelogenin and wild-type ameloblastin expression con-
structs described previously (9).An expression construct contain-
ing the Pro70Thr mutation which causes AI in humans was made
by engineering the mutation into the wild-type expression con-
struct as described previously (9). Each transfection experiment
was performed in triplicate. Transfection was achieved using
Lipofectamine 2000 according to themanufacturer’s instructions
(Invitrogen) and cultures were incubated as above in the presence
or absence of 0.5 mM sodium-4-phenylbutyrate for 18 h. Trans-
fections omitting the DNA constructs were established in parallel
as negative controls. Subsequently, cellswerefixed in ice cold 4%
paraformaldehyde andmade permeable using 0.1%TritonX-100
inPBS.CelldeathwasdetectedbyTUNELassayusingthe ‘InSitu
Cell Death’ Kit (Roche) according to the manufacturer’s instruc-
tions. Three contiguous images of each sample were collected
using the ×10 objective lens of a DMRB microscope (Leica)
and SpotTM digital camera and associated software (RTKE/SE
Diagnostic Instruments Inc.). The percentage ofTUNEL-positive
cells in each image was determined using the ‘Analyse Particles’
feature of ImageJ image analysis software (Rasband, W.S.,
ImageJ, US National Institutes of Health, Bethesda, MD, USA,
http://imagej.nih.gov/ij/, 1997–2012). Results were analysed
using the Kruskal–Wallis test followed by a Dunn’s multiple
comparison test using GraphPad Prismw v5.0 software (Graph-
Pad, San Diego, CA, USA).
Morphometric procedures
Measurements of the secretory stage enamel organ were carried
out on paraffin wax-processed, haematoxylin and eosin-stained,
longitudinal sections (6 mm), cut through the midline of the man-
dible. The distance from where the enamel matrix could first be
detected, at the apical region of the tooth, and the point, distally,
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where the ameloblasts first became disorganized was measured
using ImageJ image analysis software (see above). In wild-type
mice, the most distal measurement was the transition stage imme-
diately prior to the commencement of thematuration stage of ame-
logenesis. Ineachsection, thegreatest thicknessof secretedenamel
matrix was also measured over this distance. Hemi-mandibles of
seven untreated affected female mice, 4-phenylbutyrate-treated
affected female mice, six untreated affected male mice and eight
4-phenylbutyrate-treated affected male mice were analysed in
this way. Results were analysed using the Mann–Whitney U-test
using GraphPad Prism software (see above).
Measurements of intracellular vesicle areas were performed on
paraffinwax-processed, longitudinal sections (6 mm).Ameloblas-
tin was immunolabelled in these sections to demonstrate the vesi-
cles and three images of each specimen were collected using
deconvolution microscopy as described above. The ‘Analyse Par-
ticles’ feature of Image J image analysis software (see above) was
used to obtain the areas of individual intracellular vesicles. Four
hemi-mandibles of untreated and 4-phenylbutyrate-treated
affected female mice and affected male mice were analysed in
this way. Results were analysed by the Kruskal–Wallis test fol-
lowed by a Dunn’s multiple comparison test using GraphPad
Prism software (see above).
Statistical analyses
Statistical differences between the experimental groups in the
transfection analyses and the vesiclemeasurementswere analysed
using the non-parametric Kruskal–Wallis one-way analysis of
variance followed by Dunn’s multiple comparisons post-test.
Qualitative assessment of the appearance of affected female
mouse enamel from images taken at the beginning and end of
the 4-phenylbutyrate-treatment experiment by seven-independent
assessors was analysed using Fisher’s exact test.Measurements of
thesecretorystageenamelorganandenamelmatrix thicknesswere
compared using the two-tailed Mann–Whitney U-test. Compari-
son of gene expression by qPCR was analysed using a one-tailed
Mann–WhitneyU-test. In all statistical analyses, a ¼ 0.05.
SUPPLEMENTARYMATERIAL
Supplementary Material is available at HMG online.
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